Title: Schizophrenia and the Affective Disorders
1Chapter 16
- Schizophrenia and the Affective Disorders
2Schizophrenia
- A serious mental disorder characterized by
disordered thoughts, delusions, hallucinations,
and often bizarre behaviors - Afflicts 1 of population
- Probably the most misused psychological term
literally means split mind, so often confused
with multiple personality disorder - Positive symptoms symptoms evident by their
presence - Thought disorders disorganized, irrational
thinking (most important symptom) - Delusions a belief that is clearly in
contradiction to reality - Persecution false beliefs that others are
plotting against oneself - Grandeur false beliefs in ones own power
- Control belief that one is being controlled by
others - Hallucinations perception of a nonexistent
object or event
3Schizophrenia
- Negative symptoms characterized by the absence
of behaviors that are normally present - Flattened emotional response
- Poverty of speech
- Lack of initiative and persistence
- Inability to experience pleasure
- Social withdrawal
- Heritability
- Both adoption and twin studies indicate that
schizophrenia is a heritable trait - If there is a schizophrenia gene, then it must
be triggered by some type of envtal event - Study shows that higher paternal age is
positively correlated with diagnosis of
schizophrenia
4Pharmacology of Schizophrenia
- Dopamine hypothesis suggest that schizophrenia
is caused by overactivity of DA synapses,
probably those in the mesolimbic pathway - Effects of DA agonists and antagonist
- A drug used to prevent surgical shock,
chlorpromazine, was dramatically effective in
reducing symptoms of schizophrenia - Since this discovery, many other drugs have been
developed that relieve the positive symptoms of
schizophrenia All of these drugs block DA
receptors - DA agonists act to produce positive symptoms of
schizophrenia (e.g amphetamine, cocaine and
L-DOPA) - The mesolimbic pathway is most likely involved in
schizophrenia could be caused by reinforcing
effects of this pathway for any of the behaviors
found with positive symptoms
5Pharmacology of Schizophrenia
- Effects of DA agonists and antagonist
- Schizophrenics often report feelings of elation
and euphoria at the beginning of a schizophrenic
episode, suggesting that this is caused by
hyperactivity of DA neurons involved in
reinforcement - Paranoid delusions may be caused by increased
activity of the DA input to the amygdala - Amygdala is involved with conditioned emotional
responses for aversive events - DA transmission abnormalities
- DA neurons may release more DA
- Amphetamine administration caused the release of
more DA in the striatum of schizophrenic
patients patients with greater amounts of DA
showed greater increases in positive symptoms - There may be moderate increases in the numbers of
D2 receptors, but it is unlikely that that is the
cause of the disorder - Clozapine an atypical antipsychotic drug
blocks D4 receptors in the nucleus accumbens
6Pharmacology of Schizophrenia
- Long-term drug treatment
- The symptoms of up to 1/3 of all schizophrenic
patients are not substantially reduced by
antipsychotic drugs - Many drugs produce serious side effects
- Until recently, all drugs caused at least some
symptoms resembling those of Parkinsons disease
slow movement, lack of facial expression, general
weakness - Tardive dyskinesia a movement disorder that can
occur after prolonged treatment with
antipsychotic medication, characterized by
involuntary movements of the face and neck - Caused by overstimulation of DA receptors
- Why would antagonists cause overstimulation of DA
receptors? - Supersensitivity the increased sensitivity of
NT receptors caused by damage to the afferent
axons or long-term blockage of NT release - However, new drugs have been developed that do
not produce these long-term side effects
atypical antipsychotic drugs (Clozapine)
7Schizophrenia as a neurological disorder
- Whereas the positive symptoms are unique to
schizophrenia, the negative symptoms are similar
to those produced by brain damage caused by
several different means - Brain abnormalities in schizophrenia
- Patients with schizophrenia exhibit neurological
symptoms that suggest brain damage (e.g. poor
control of eye movements, unusual facial
expressions) - This suggests that schizophrenia may be
associated with brain damage of some kind - MRI and CT studies have found loss of brain
tissue in patients with schizophrenia - Relative size of lateral ventricles was more than
twice the size of control subjects
8Schizophrenia as a neurological disorder
- Possible causes of brain abnormalities
- Why do less than ½ the children of schizophrenic
patients become schizophrenic? - Perhaps what is inherited is a susceptibility to
environmental factors that may lead to some type
of brain damage - Development of disorder is most likely caused by
interaction b/t genes and environment - However, people can develop schizophrenia without
and family history - Epidemiology study of distribution and causes
of diseases in populations try to correlate
disease frequencies with factors that are present
in the envt - People born during late winter and early spring
are more likely to develop schizophrenia
seasonality effect - Possibly caused by higher likelihood of mother
contracting viral illness - Also more likely to occur in cities rather than
countryside
9Schizophrenia as a neurological disorder
- Possible causes of brain abnormalities
- People born far from the equator are more likely
to develop schizophrenia latitude effect - Decreased winter temp may magnify seasonality
effects - Famine (especially thiamine deficiency) during
pregnancy may cause schizophrenia in offspring - Underweight women are more likely to give birth
to babies who later develop schizophrenia low
birth-weight babies have higher incidence of
schizophrenia - Vitamin D deficiency
- Rh incompatibility
- Red blood cells of Rh-positive person contain Rh
factor - If fetus is Rh incompatible with mother, then
increased likelihood of schizophrenia in offspring
10Schizophrenia as a neurological disorder
- Evidence for abnormal brain development
- Prenatal brain development of children who become
schizophrenic is not normal - Reports of both behavioral and anatomical
abnormalities - Children who later became schizophrenic displayed
more negative affect in their facial expressions
and were more likely to show abnormal movements - Some monozygotic twins are discordant (i.e. one
develops it, the other does not) for
schizophrenia difference in brain structure (one
has larger ventricles, degeneration in specific
regions of cerebral cortex) - Monochorionic (share one placenta) vs.
dichorionic (separate placentas) in monozygotic
twins concordance rate for schizophrenia was
lower in dichorionic vs. monochorionic - Schizophrenia not caused by degeneration, but by
a rapid loss of brain volume during young
adulthood - Does not involve death of neurons, but a loss of
neuropil,the network of dendrites and axons in
the brain
11Schizophrenia as a neurological disorder
- Positive and negative symptoms Prefrontal cortex
- Is there a relationship b/t the 2 categories of
symptoms? - Negative symptoms caused by hypofrontality
(decreased activity of the frontal lobes),
primarily in the dorsolateral prefrontal cortex - May be caused by decrease in release of DA in
prefrontal cortex, mediated mostly by D1
receptors - Chronic abuse of PCP (indirect glutamate
antagonist) causes a decrease of metabolic
activity in frontal lobes - Chronic PCP treatment reduces DA activity in the
prefrontal cortex, which in turn produces
hypofrontality that appears to be responsible for
the negative symptoms of schizophrenia - Prefrontal hypoactivity (neg. symptoms) causes
mesolimbic DA hyperactivity (pos. symptoms) - Clozapine causes an increase in DA release in
prefrontal cortex, and decrease of DA release in
nucleus accumbens
12Major Affective Disorders
- Affect refers to feelings or emotions
- Major affective disorders a serious mood
disorder includes unipolar and bipolar disorder - Bipolar disorder characterized by cyclical
periods of mania (extreme elation) and depression
(extreme despair) episodes of mania generally
shorter than episodes of depression - Unipolar depression consists of unremitting
depression or periods of depression that do not
alternate with periods of mania - Depression causes very little energy, crying,
inability to experience pleasure, disturbed
sleep, depressed bodily functions - Mania involves sense of euphoria, nonstop speech
and motor activity, easily angered, go without
sleep
13Major Affective Disorders
- Heritability
- The tendency to develop a major affective
disorder is heritable - A single dominant gene is responsible for
susceptibility to developing bipolar disorder - Physiological treatments
- MAO inhibitors
- Drugs (e.g. Iproniazid) that inhibit the activity
of MAO, the enzyme that destroys excess monoamine
transmitter substance within terminal buttons,
increase the release of DA, NE and 5-HT - Have serious side effects, e.g. cheese effect
with pressor amines - Tricyclic antidepressants
- Inhibit the reuptake of 5-HT and NE by terminal
buttons - This keeps the NT in contact with the
postsynaptic receptor, thus prolonging the
postsynaptic potentials - Specific serotonin reuptake inhibitors (SSRI)
- Inhibit reuptake of 5-HT
- Widely prescribed for depression and for symptoms
of OCD and social phobia
14Major Affective Disorders
- Physiological treatments
- Electroconvulsive therapy (ECT)
- Electrodes placed on patients scalp deliver a
jolt of electricity to trigger a seizure - Most effective with mania and depression
- Effects are rapid, as compared to drugs
- Lithium
- Most effective in treating the manic phase of
bipolar disorder - Does not suppress normal feelings of emotion
- Does not impair intellectual processes
- Does have some side effects, including hand
tremors, weight gain, excessive urine production
and thirst - Some patients with bipolar disorder have trouble
continuing with medication - Those who cannot tolerate side effects can take
carbamazepine, an anti-seizure medication
15Major Affective Disorders
- Role of monoamines
- Monoamine hypothesis hypothesis that states that
depression is caused by a low level of activity
of one or more monoaminergic synapses - Since the symptoms of depression do not respond
to potent DA agonists (e.g. amphetamine or
cocaine), researchers have focused on NE and 5-HT - Depression can be caused by monoamine antagonists
- e.g. reserpine
- Suicidal depression is related to decreased CSF
levels of 5-HIAA, a metabolite of 5-HT that is
produced when MAO breaks it down - Families of subjects with low levels of 5-HIAA
were more likely to include people with
depression - Suggests that 5-HT metabolism or release is
genetically controlled and is linked to depression
16Major Affective Disorders
- Role of monoamines
- Tryptophan depletion procedure
- Depressed patients currently taking medication
- Gave low-tryptophan diet, follwed by an amino
acid cocktail, which would inhibit what little
tryptophan was left from entering the brain - Tryptophan depletion caused most of the patients
to relapse back into depression - However, recovered after resuming normal diet
- This has no effect on healthy, non-depressed
subjects, but does lower the mood of people with
a family history of affective disorders
17Major Affective Disorders
- A role for Substance P?
- A peptide secreted as a NT and neuromodulator in
several regions of the brain - May be involved in emotional behavior, the
response to stress, and the symptoms of
depression - Long-term admin of antidepressants cause a
reduction of substance P levels in several
regions of the brain - MK-869, a drug that blocks the receptor for
substance P (NK1) shows a reduction in depressive
symptoms - Substance P antagonists appear to act
independently of drugs that reduce depression by
blocking the reuptake of 5-HT and NE
18Major Affective Disorders
- Evidence for brain abnormalities
- Studies have found abnormalities in the
prefrontal cortex, basal ganglia, and cerebellum
of patients with unipolar depression, and
abnormalities of the cerebellum in those with
bipolar disorder - Found in young patients, which suggests the
presence of a developmental abnormality or a
degenerative process that occurs early in life - Repeated episodes of depression and mania caused
an increase in the size of the lateral ventricles - The amygdala and several regions of the
prefrontal cortex play a role in the development
of depression - Activity of amygdala of depressed patients was
correlated with the severity of their depression
- Orbitofrontal cortex generally more active in
depressed patients - Subgenual prefrontal cortex shows a lower level
of activation in depressed patients activity in
this region is increased during manic episodes
19Major Affective Disorders
- Evidence for brain abnormalities
- Silent cerebral infarctions
- A small cerebrovascular accident (stroke) that
causes minor brain damage without producing
obvious neurological symptoms - Appears to be a major cause of late-onset
depression (first occurs later in life) - Risk factors are similar for stroke (e.g.
smoking, hypertension)
20Major Affective Disorders
- Role of circadian rhythms
- One of the most prominent symptoms of depression
is disordered sleep - Sleep of depressed individuals is shallow, Stages
3 4 are reduced, Stage 1 is increased - REM sleep occurs earlier
- Selective deprivation of REM sleep alleviates
depression - The effect occurs slowly like that of drugs
- Other treatments for depression suppress REM
sleep, suggesting that REM sleep and mood may be
correlated - Successful ECT treatments suppress REM sleep in
depressed patients - Total sleep deprivation produces immediate
effects - Perhaps, during sleep a substance is produced
that has a depressogenic effect - Depressed patients whose moods fluctuate more
often will benefit from sleep deprivation more
21Major Affective Disorders
- Role of Zeitgebers
- Seasonal affective disorder a mood disorder
characterized by depression, lethargy, sleep
disturbances, and craving for carbohydrates
during the winter season when days are short - Summer depression a mood disorder characterized
by depression, sleep disturbances, and loss of
appetite - Seasonal affective disorder appears to have a
genetic basis - Molecular genetic studies suggest that seasonal
affective disorder may be linked to genes
involved in production of the 5-HT transporter
and the 5-HT2A receptor - SAD can be treated with phototherapy, treatment
of exposing people to bright light for several
hours a day